Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 790 of 1,261

  1. US 8846643

    Phosphonates with reduced toxicity for treatment of viral infections

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  2. US 8846102

    Non-viral compositions and methods for transfecting gut cells in vivo

    ENGENE, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  3. US 8846605

    Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

    FIRSTRING RESEARCH, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  4. US 8846713

    Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  5. US 8846066

    Methods and related compositions for reduction of fat and skin tightening

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  6. US 8846057

    Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  7. US 8846056

    Anti-RSV immunogens and methods of immunization

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  8. US 8846051

    Modulation of replicative fitness by deoptimization of synonymous codons

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  9. US 8846040

    Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  10. US 8846034

    Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

    HALOZYME, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  11. US 8846088

    Melt granulation of a composition containing a calcium-containing compound

    TAKEDA NYCOMED AS · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  12. US 8846020

    Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof

    REGENTIS BIOMATERIALS LTD. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  13. US 8846006

    MRI markers, delivery and extraction systems, and methods of manufacture and use thereof

    The Board of Regents of the University of Texas System · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  14. US 8845801

    Bone cement and method

    Regents of the University of Minnesota · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  15. US 8846649

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  16. US 8846889

    Peptide biosynthesis and pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  17. US 8846913

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  18. US 8847004

    Humanized M-CSF mice

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  19. US 8846918

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  20. US 8841266

    Pharmaceutical composition and method for regulating abnormal cellular proliferation

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  21. US 8841273

    Methods and compositions for anti-EGFR treatment

    The Board of Regents of the University of Texas System · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  22. US 8840926

    Sialic acid analogs

    Ultragenyx Pharmaceutical Inc. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  23. US 8840905

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  24. US 8840886

    Method of treating cancer with DLL4 antagonist and chemotherapeutic agent

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.